Topical Caffeine for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Topical Caffeine for Hair Regrowth

Created on 09/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Topical caffeine, a low-cost cosmetic applied to the scalp in shampoos or leave-on liquids, is used to slow hereditary pattern hair thinning. Laboratory results are plausible, but human evidence is thin, much of it funded by the leading brand's maker, and evidence for regrowth is weaker still. Harms appear minimal: occasional mild scalp irritation. The main risk is delaying a stronger treatment; it is most often used as an add-on. (Full Review)

Protocol

Rinse-off shampoo
About 7 mL of 1% caffeine, daily
Lathered and left for 2 minutes before rinsing, for 6 months in trials
Leave-on liquid
2 mL of 0.2% caffeine, twice daily
Applied to the scalp morning and evening, for 6 months in the main trial
Caffeine as an add-on (dermatology approach)
With minoxidil, finasteride or ketoconazole
As in compounded formulas that add caffeine to minoxidil solutions
Time to effect
Reduced shedding
3 months
Seen in trials
Structural changes
6 months
Growing-hair proportion and density; judging earlier is unreliable because of seasonal shedding swings

Benefits

Contraindications
  • Positive patch test to caffeine or to a listed product ingredient (e.g., fragrance mix, the preservative methylisothiazolinone)
  • Active scalp dermatitis, open wounds or erosions on the scalp (until healed)
  • Suspected scarring alopecia (e.g., lichen planopilaris, frontal fibrosing alopecia) or sudden patchy loss (before a dermatologist's diagnosis)
  • Children under 18 years
    •
Key Interactions
  • Topical minoxidil (prescription and over-the-counter, e.g., Rogaine): Caution; stacked vehicles raise scalp irritation
  • Topical retinoids (vitamin A–derived skin drugs; tretinoin, adapalene): Caution; increased caffeine penetration and irritation
  • CYP1A2 inhibitors (fluvoxamine, ciprofloxacin, oral contraceptives): Monitor; slower clearance of dietary caffeine
  • Keratolytic scalp products (agents that loosen the outer skin layer; salicylic acid, coal-tar shampoos): Caution; increased stinging and absorption
  • Ketoconazole shampoo (antifungal, over-the-counter 1% or prescription 2%): No harmful interaction; monitoring for cumulative dryness
  • Oral caffeine sources (coffee, pre-workout formulas, energy drinks, guarana, green tea extract): Monitor; dietary intake sets the risk
  • Hair-supportive supplements and topicals with additive effects (topical adenosine, rosemary oil, saw palmetto, melatonin solution): Caution; higher irritation and contact-allergy risk
  • Microneedling and scalp procedures: Caution; multiplied absorption and irritation
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Scalp irritation & cosmetic changes; Allergic contact dermatitis to product ingredients; Delayed effective treatment
    •
  • Speculative: Systemic stimulant effects; Follicle suppression at high concentrations
    •

Monitoring

Marker Target Why
Ferritin 70–150 ng/mL Iron stores for hair growth
Thyroid-stimulating hormone (TSH) 1.0–2.5 mIU/L Thyroid dysfunction causes diffuse shedding
25-hydroxy vitamin D 40–60 ng/mL Deficiency linked to shedding
Zinc (serum) 90–120 µg/dL Deficiency causes shedding
Hair pull test 0–2 hairs per pull of about 50 hairs Tracks active shedding
Global scalp photographs No established numeric target; track change from own baseline Documents density and coverage
Trichoscopy (magnified scalp examination) or phototrichogram (photographic hair count) density No established target; track change in hairs/cm² from own baseline Objective hair count and thickness
Androgen testing No target stated; baseline test in women with irregular cycles or acne Rules out treatable causes of shedding
Free T4 (main circulating thyroid hormone) No target stated; paired with TSH Thyroid dysfunction causes diffuse shedding

Cadence: Baseline before starting (blood tests for ferritin, thyroid function and vitamin D; androgen testing for women with irregular cycles or acne); photographs and pull test at 3 months, 6 months, then every 6–12 months; blood tests repeated at 6 months only if baseline values were low

Qualitative Assessment

  • Hairs shed in the shower drain and brush compared with baseline
  • Width of the central parting and visibility of the scalp under bright light
  • Hair texture, strength and ease of styling
  • Scalp comfort: itching, stinging, dryness or flaking after application
  • Self-rated satisfaction with coverage and appearance
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.